Where does Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico ranks #31,672 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

Is Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patent grant rate increasing or decreasing?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's recent grant velocity is -40% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patents?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patents average 12.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico

Q: How many patents does Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico hold?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico holds 8 US utility patents granted between 2015 and 2024, spanning 10 technology areas.

Q: What is Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's Innovation Score?

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico has an Innovation Score of 39.3 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Q: How is the Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 8 granted patents across 10 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Fondazione ranks #31,672 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 10 technology areas.

#31,672
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.3/100): 12.0
avg claims per patent: -40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R31672 · Foreign Corporation #31,672 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #31,672/49,997
PHOTO-FINISH Focal Therapeutics
CPC-FOCUS A61B · 10 areas
INNOV-THIN 39.3/100
CLAIMS-RICH 12.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Focal Therapeutics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Fondazione’s 39.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (19%) Velocity 13.3 pts (34%) Breadth 11.2 pts (28%) Claim depth 7.2 pts (18%)

Qualcomm Incorporated · highest

85
Fondazione Irccs… · this assignee

39
3D Lighting… · lowest

7

What this shows Fondazione's Innovation Score is 39.3/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Fondazione?

Each dot is one of Fondazione’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Fondazione’s own 12.0 claims/patent is at or below the 13.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Fondazione vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Fondazione's grants concentrate

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico is a focused PatentsView assignee: 10 CPC subclasses with 25% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2017. By volume, Fondazione sits between Focal Therapeutics Inc. and Fourth Military Medical University.

Fondazione's three-year grant acceleration

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Focal Therapeutics

8
Foci Fiber Optic…

8
Focuslight

8
FON Wireless

8
Fontanaarte S p A

8
Fostag Formenbau

8
Founder Mobile Me…

8
Fourth Military M…

8
Fondazione Irccs… ◀

8

What this shows Fondazione holds 8 patents at rank #31,636, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Fondazione

By rank, the assignees closest to #31,636 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Fondazione's primary technology class.

Fondazione's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	25.0%
2016	2	25.0%
2017	1	12.5%
2020	1	12.5%
2023	1	12.5%
2024	1	12.5%

Which technologies does Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico patent most?

A61B - DIAGNOSIS; SURGERY; Identification 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

G06T - Image Data Processing OR Generation, IN General 1

A61G - Transport, Personal Conveyances, OR Accommodation Specially Adapted FOR Patients OR Disabled Persons ; Operating Tables OR CHAIRS; Chairs FOR DENTISTRY; Funeral Devices 1

C07K - Peptides 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's patent record in context - here's where to go next.

Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 25% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #31,672 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Fondazione Irccs Ca'granda-ospedale Maggiore Policilinico against Focal Therapeutics Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.